An observational study in Coronary Artery Disease, Coronary Stenosis and Coronary Occlusion, sponsored by University Hospital, Basel, Switzerland. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-10.
Sponsored by University Hospital, Basel, Switzerland · Observational
This registry aims to learn more about the best ways to treat coronary artery disease. Information from routine medical care will be collected to compare different treatment approaches, including drug-eluting stents, drug-coated balloons (DCB), and bioresorbable scaffolds (BRS), which gradually dissolve over time. The registry will include people with coronary artery disease who receive an intervention (percutaneous coronary intervention), including those undergoing more complex procedures. By studying treatment outcomes over time, the Registry aims to better understand which therapies work best for different groups of patients and to improve future care for people with coronary artery disease.
The PCI Registry Basel is established to systematically collect real-world data on all patients (≥18 years) undergoing percutaneous coronary interventions (PCI) at the University Hospital Basel. The primary purpose of the registry is to investigate the best treatment strategies in patients with coronary artery disease (CAD) and their associated outcomes in routine clinical practice, including complex procedures (e.g. chronic total occlusions (CTO), bifurcation lesions, left main interventions), the use of drug-coated balloons (DCB) and bioresorbable scaffolds (BRS), as well as standard drug-eluting stent (DES) implantation.
Data are derived retrospectively from routine clinical practice at the University Hospital Basel. Relevant procedural, clinical, and follow-up information is extracted from existing sources such as the catheterization lab reports, and the electronic health record (Cardioapp). No additional data collection or invasive study-specific interventions are performed for the purpose of this registry.
Where applicable, data from previous research projects or registries may also be incorporated, provided that all legal and ethical requirements are satisfied. All data will be pseudonymised before analysis. A secure decoding key linking registry numbers to patient identifiers is kept separately and is accessible only to authorized personnel under the responsibility of the Principal Investigator.
The study population consits of patients undergoing percutaneous coronary interventions (PCI) at the University Hospital Basel
Patients treated at the University Hospital Basel
Exclusion Criteria:
Target Vessel Failure (TVF)
Composite endpoint defined as the occurrence of cardiovascular death, target vessel myocardial infarction, or unplanned target vessel revascularisation.
Time frame: Through study completion, an average of 1 year
All-Cause Mortality
Death from any cause as documented in the available medical records.
Time frame: Through study completion, an average of 1 year
Cardiovascular Mortality
Death attributed to a cardiovascular cause as documented in the medical records.
Time frame: Through study completion, an average of 1 year
Occurrence of Myocardial Infarction
Documented occurrence of myocardial infarction in the medical records.
Time frame: Through study completion, an average of 1 year
Procedural Success Rate
Proportion of PCI procedures meeting the predefined criteria for procedural success.
Time frame: Through study completion, an average of 1 year
Procedural Complication Rate
Proportion of PCI procedures with documented procedural complications
Time frame: Through study completion, an average of 1 year
Rate of Rescue Stenting
Proportion of PCI procedures requiring unplanned rescue stent implantation.
Time frame: Through study completion, an average of 1 year
Unplanned hospitalisation for angina
Unplanned hospitalisation due to angina as documented in the medical records
Time frame: Through study completion, an average of 1 year
Unplanned hospitalisation for heart failure
Unplanned hospitalisation due to heart failure, as documented in the medical records.
Time frame: Through study completion, an average of 1 year
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Basel, Switzerland